What is Hip Osteoarthritis?
A Hip osteoarthritis (OA) is a degenerative joint condition where the cartilage that cushions the ends of the bones in the hip joint gradually wears down over time. This cartilage breakdown leads to bone-on-bone contact, causing pain, inflammation, stiffness, and reduced mobility. It is a common form of arthritis, often related to aging, joint overuse, previous injury, or genetic factors, and can significantly impact daily activities like walking, sitting, or climbing stairs.
Causes Of Hip Osteoarthritis
Hip osteoarthritis (OA) develops when the protective cartilage in the hip joint gradually breaks down, leading to bone-on-bone friction. Several factors can contribute to this process, including:
- Age and Joint Wear – Natural aging leads to cartilage degeneration over time.
- Joint Injury or Trauma – Previous hip injuries or fractures can increase the risk.
- Genetics – A family history of OA can make you more susceptible.
- Obesity – Excess body weight adds stress to the hip joint.
- Repetitive Strain – High-impact sports or occupations involving heavy physical work can accelerate wear and tear.
- Hip Dysplasia or Structural Abnormalities – Abnormal joint shapes or alignment issues can cause uneven joint loading.
- Inflammation and Autoimmune Conditions – Conditions like rheumatoid arthritis can increase OA risk.
Treat Hip Osteoarthritis without Surgery
During your visit, ORTHOReNEW Expert will examine your body in motion and may use ultrasound to observe the inner workings of the hip in real time. This will give a doctor a more accurate picture of root cause or triggers to your pain, how function is affected, and any other problem problem.
Once you’ve been evaluated, your physician will customize a treatment plan based on your specific needs. Treatments may include:
ORTHOReNEW - Regenexx-SD Injectate
Procedures using Regenexx-SD injectate include a patented protocol that utilizes Bone Marrow Concentrate (BMC), which contains the patient’s own mesenchymal stem cells. The cell processing for a Regenexx-SD injectate routinely achieves 20x concentration— above what non-Regenexx cell processing can achieve.
ORTHOReNEW - Regenexx-SCP Injectate
Procedures using Regenexx-SCP injectate represent a supercharged version of platelet-rich plasma (PRP). In this process, blood is drawn, then processed to isolate the platelets and growth factors. The growth factors are then purified, concentrated, and injected into the hip area using imaging guidance for precision. Regenexx-SCP injectate provides a higher concentration of growth factors than typical PRP procedures.